Introduction
Hospital Acquired Pneumonia (HAP) - Overview
Hospital Acquired Pneumonia (HAP) - Therapeutics Development
Hospital Acquired Pneumonia (HAP) - Therapeutics Assessment
Hospital Acquired Pneumonia (HAP) - Companies Involved in Therapeutics Development
Hospital Acquired Pneumonia (HAP) - Drug Profiles
Hospital Acquired Pneumonia (HAP) - Dormant Projects
Hospital Acquired Pneumonia (HAP) - Discontinued Products
Hospital Acquired Pneumonia (HAP) - Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Hospital Acquired Pneumonia (HAP), 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Companies, 2021 (Contd..1)
Products under Development by Companies, 2021
Products under Development by Companies, 2021 (Contd..1)
Products under Development by Companies, 2021 (Contd..2)
Products under Development by Companies, 2021 (Contd..3)
Products under Development by Companies, 2021 (Contd..4)
Products under Development by Companies, 2021 (Contd..5)
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Hospital Acquired Pneumonia (HAP) - Pipeline by AiCuris AG, 2021
Hospital Acquired Pneumonia (HAP) - Pipeline by Antabio SAS, 2021
Hospital Acquired Pneumonia (HAP) - Pipeline by Aridis Pharmaceuticals Inc, 2021
Hospital Acquired Pneumonia (HAP) - Pipeline by AstraZeneca Plc, 2021
Hospital Acquired Pneumonia (HAP) - Pipeline by Auspherix Pty Ltd, 2021
Hospital Acquired Pneumonia (HAP) - Pipeline by Biolytx Pharmaceuticals Corp, 2021
Hospital Acquired Pneumonia (HAP) - Pipeline by Bioversys AG, 2021
Hospital Acquired Pneumonia (HAP) - Pipeline by Cellular Biomedicine Group Inc, 2021
Hospital Acquired Pneumonia (HAP) - Pipeline by Centauri Therapeutics Ltd, 2021
Hospital Acquired Pneumonia (HAP) - Pipeline by Clarametyx Biosciences Inc, 2021
Hospital Acquired Pneumonia (HAP) - Pipeline by ContraFect Corp, 2021
Hospital Acquired Pneumonia (HAP) - Pipeline by Cumberland Pharmaceuticals Inc, 2021
Hospital Acquired Pneumonia (HAP) - Pipeline by CytaCoat AB, 2021
Hospital Acquired Pneumonia (HAP) - Pipeline by Destiny Pharma Plc, 2021
Hospital Acquired Pneumonia (HAP) - Pipeline by Dong-A Socio Holdings Co Ltd, 2021
Hospital Acquired Pneumonia (HAP) - Pipeline by EnBiotix Inc, 2021
Hospital Acquired Pneumonia (HAP) - Pipeline by Evotec SE, 2021
Hospital Acquired Pneumonia (HAP) - Pipeline by GangaGen Biotechnologies Pvt Ltd, 2021
Hospital Acquired Pneumonia (HAP) - Pipeline by Helperby Therapeutics Group Ltd, 2021
Hospital Acquired Pneumonia (HAP) - Pipeline by Hoth Therapeutics Inc, 2021
Hospital Acquired Pneumonia (HAP) - Pipeline by Hypo-Stream Ltd, 2021
Hospital Acquired Pneumonia (HAP) - Pipeline by La Jolla Pharmaceutical Company, 2021
Hospital Acquired Pneumonia (HAP) - Pipeline by Meiji Seika Pharma Co Ltd, 2021
Hospital Acquired Pneumonia (HAP) - Pipeline by Merck & Co Inc, 2021
Hospital Acquired Pneumonia (HAP) - Pipeline by Motif Bio Plc, 2021
Hospital Acquired Pneumonia (HAP) - Pipeline by Nabriva Therapeutics Plc, 2021
Hospital Acquired Pneumonia (HAP) - Pipeline by Nosopharm SAS, 2021
Hospital Acquired Pneumonia (HAP) - Pipeline by Omnix Medical Ltd, 2021
Hospital Acquired Pneumonia (HAP) - Pipeline by Peptineo, 2021
Hospital Acquired Pneumonia (HAP) - Pipeline by Polyphor Ltd, 2021
Hospital Acquired Pneumonia (HAP) - Pipeline by Pulmobiotics SL, 2021
Hospital Acquired Pneumonia (HAP) - Pipeline by Qilu Pharmaceutical Co Ltd, 2021
Hospital Acquired Pneumonia (HAP) - Pipeline by Shionogi & Co Ltd, 2021
Hospital Acquired Pneumonia (HAP) - Pipeline by Spero Therapeutics Inc, 2021
Hospital Acquired Pneumonia (HAP) - Pipeline by TGV-Inhalonix Inc, 2021
Hospital Acquired Pneumonia (HAP) - Pipeline by VenatoRx Pharmaceuticals Inc, 2021
Hospital Acquired Pneumonia (HAP) - Pipeline by Wockhardt Ltd, 2021
Hospital Acquired Pneumonia (HAP) - Dormant Projects, 2021
Hospital Acquired Pneumonia (HAP) - Dormant Projects, 2021 (Contd..1)
Hospital Acquired Pneumonia (HAP) - Discontinued Products, 2021

List of Figures
Number of Products under Development for Hospital Acquired Pneumonia (HAP), 2021
Number of Products under Development by Companies, 2021
Number of Products by Top 10 Targets, 2021
Number of Products by Stage and Top 10 Targets, 2021
Number of Products by Top 10 Mechanism of Actions, 2021
Number of Products by Stage and Top 10 Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Molecule Types, 2021
Number of Products by Stage and Molecule Types, 2021

Companies Mentioned
• AiCuris AG
• Antabio SAS
• Aridis Pharmaceuticals Inc
• AstraZeneca Plc
• Auspherix Pty Ltd
• Biolytx Pharmaceuticals Corp
• Bioversys AG
• Cellular Biomedicine Group Inc
• Centauri Therapeutics Ltd
• Clarametyx Biosciences Inc
• ContraFect Corp
• Cumberland Pharmaceuticals Inc
• CytaCoat AB
• Destiny Pharma Plc
• Dong-A Socio Holdings Co Ltd
• EnBiotix Inc
• Evotec SE
• GangaGen Biotechnologies Pvt Ltd
• Helperby Therapeutics Group Ltd
• Hoth Therapeutics Inc
• Hypo-Stream Ltd
• La Jolla Pharmaceutical Company
• Meiji Seika Pharma Co Ltd
• Merck & Co Inc
• Motif Bio Plc
• Nabriva Therapeutics Plc
• Nosopharm SAS
• Omnix Medical Ltd
• Peptineo
• Polyphor Ltd
• Pulmobiotics SL
• Qilu Pharmaceutical Co Ltd
• Shionogi & Co Ltd
• Spero Therapeutics Inc
• TGV-Inhalonix Inc
• VenatoRx Pharmaceuticals Inc
• Wockhardt Ltd